Assessment of body composition in health and disease using bioelectrical impedance analysis (BIA) and dual energy X‐ray absorptiometry (DXA): a critical overview

M Marra, R Sammarco, A De Lorenzo… - Contrast media & …, 2019 - Wiley Online Library
The measurement of body composition (BC) represents a valuable tool to assess nutritional
status in health and disease. The most used methods to evaluate BC in the clinical practice …

Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters

C Smit, S De Hoogd, RJM Brüggemann… - Expert opinion on drug …, 2018 - Taylor & Francis
Introduction: The rising prevalence of obesity confronts clinicians with dosing problems in
the (extreme) overweight population. Obesity has a great impact on key organs that play a …

[PDF][PDF] (2022)

T Zhang, EH Krekels, C Knibbe - … in the obese …, 2013 - scholarlypublications …
Introduction: Obesity is associated with many physiological changes. We review available
evidence regarding five commonly accepted assumptions to a priori predict the impact of …

Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes

T Zhang, EHJ Krekels, C Smit… - Expert opinion on drug …, 2022 - Taylor & Francis
Introduction Obesity is associated with many physiological changes. We review available
evidence regarding five commonly accepted assumptions to a priori predict the impact of …

[HTML][HTML] Chloroquine for SARS-CoV-2: implications of its unique pharmacokinetic and safety properties

C Smit, MYM Peeters, JN van den Anker… - Clinical …, 2020 - Springer
Since in vitro studies and a preliminary clinical report suggested the efficacy of chloroquine
for COVID-19-associated pneumonia, there is increasing interest in this old antimalarial …

Effect of lipophilicity on drug distribution and elimination: influence of obesity

CD Bruno, JS Harmatz, SX Duan… - British Journal of …, 2021 - Wiley Online Library
Aims For a given passively‐distributed lipophilic drug, the extent of in vivo distribution
(pharmacokinetic volume of distribution, Vd) in obese individuals increases in relation to the …

Gender differences in clinical registration trials: is there a real problem?

G Labots, A Jones, SJ de Visser… - British journal of …, 2018 - Wiley Online Library
Aims Several studies have reported the under‐representation of women in clinical trials,
thereby challenging the external validity of the benefit/risk assessments of launched drugs …

[HTML][HTML] The impact of diet and exercise on drug responses

E Niederberger, MJ Parnham - International journal of molecular sciences, 2021 - mdpi.com
It is well known that lifestyle changes can alter several physiological functions in the human
body. For exercise and diet, these effects are used sensibly in basic therapies, as in …

[HTML][HTML] Clinical pharmacokinetics and pharmacodynamics of micafungin

RE Wasmann, EW Muilwijk, DM Burger… - Clinical …, 2018 - Springer
Micafungin is a selective inhibitor of the synthesis of fungal 1, 3-β-d-glucan, an essential
component of the fungal cell wall. It is available as a powder for infusion only and is …

[HTML][HTML] Correlation of body weight and composition with hepatic activities of cytochrome P450 enzymes

V Krogstad, A Peric, I Robertsen, MK Kringen… - Journal of …, 2021 - Elsevier
Obesity is associated with comorbidities of which pharmacological treatment is needed.
Physiological changes associated with obesity may influence the pharmacokinetics of drugs …